{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Austin", "organization": "", "rank": 1, "lastname": "FRAKT"}], "original": "By AUSTIN FRAKT"}, "news_desk": "Upshot", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbWide.jpg", "legacy": {"wide": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/23/upshot/23up-healthdrugs-test/23up-healthdrugs-test-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"content_kicker": "The New Health Care", "main": "How to Make the Most of Drugs We Already Have"}, "print_page": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Inventions and Patents", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Labeling and Labels (Product)", "is_major": "N", "rank": "6", "name": "subject"}], "snippet": "Getting the incentives right for new uses can give us more safety and more value for our health care dollar.", "source": "The New York Times", "lead_paragraph": "Getting the incentives right for new uses can give us more safety and more value for our health care dollar.", "word_count": "934", "pub_date": "2016-02-23T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "The Upshot", "web_url": "http://www.nytimes.com/2016/02/23/upshot/drugs-fda.html", "_id": "56caf67638f0d873cb95049d"}